X0206 3 2020-09-23 0 0001806310 Taysha Gene Therapies, Inc. TSHA 0001665124 Nagendran Sukumar C/O TAYSHA GENE THERAPIES, INC. 2280 INWOOD ROAD DALLAS TX 75235 1 0 0 0 Series B Preferred Stock Common Stock 19226 D Stock Option (right to buy) 14.90 2030-09-02 Common Stock 8171 D Each share of Series B Preferred Stock is convertible at any time at the option of the holder, without payment of additional consideration, into Common Stock, on a one-for-1.0895 basis, has no expiration date will automatically convert into shares of Common Stock upon the closing of the Issuer's initial public offering. 25% of the shares subject to the Option vest on July 28, 2021, with the remaining shares vesting in equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. Exhibit List - Exhibit 24 - Power of Attorney /s/ Kamran Alam, Attorney-in-Fact 2020-09-23